Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia. - Wikidata - awgldk - TriplyDB

Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia.

Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia.

http://www.wikidata.org/entity/Q35186322

about

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance Molecular evolution of multiple-level control of heme biosynthesis pathway in animal kingdom Bcrp1 transcription in mouse testis is controlled by a promoter upstream of a novel first exon (E1U) regulated by steroidogenic factor-1 Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists.Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.A new ABCG2 null allele with a 27-kb deletion including the promoter region causing the Jr(a-) phenotype.PharmGKB summary: very important pharmacogene information for ABCG2.Identification of SNPs involved in regulating a novel alternative transcript of P450 CYP6ER1 in the brown planthopper.

P2860

Q26865927-721CB1E8-3EF5-43F2-AF4E-2FF87EBDFD90 Q27329732-64114A60-A9DF-4BC0-AEC5-40ABBF8582F9 Q37416153-87AAFAB1-367B-44E8-A0DA-74BA57520402 Q37630384-FB140942-135D-4011-8A12-1EA31207EBF4 Q37958162-A8081B9B-E652-4422-A620-64E84D543A39 Q41671729-6F65A371-1BB6-4F0C-8EF6-7748F986ECD7 Q46018199-ED51E110-DBBC-4FA0-A737-63567D6BF14F Q48213509-DD1CC2E8-0872-4BC9-8840-EE9EE24C991D

P2860

Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia.

http://www.wikidata.org/entity/Q35186322

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Identification of a novel, tis ...... ute megakaryoblastic leukemia.

@ast

Identification of a novel, tis ...... ute megakaryoblastic leukemia.

@en

type

label

Identification of a novel, tis ...... ute megakaryoblastic leukemia.

@ast

Identification of a novel, tis ...... ute megakaryoblastic leukemia.

@en

prefLabel

Identification of a novel, tis ...... ute megakaryoblastic leukemia.

@ast

Identification of a novel, tis ...... ute megakaryoblastic leukemia.

@en

P1433

Q35186322-1A5CE344-DA9E-42C0-A49D-F01525F09885

P1476

Q35186322-750CD459-B7CA-4AC8-8F2D-3539706E254B

P2093

Q35186322-089A446D-1496-4C73-AF5A-727AFF03B0CE

Q35186322-35E241DC-6FA1-41F8-98D0-6C953422E95E

Q35186322-3718A999-C628-4C6C-B7A7-298FDDADACCD

Q35186322-3C782639-B15B-483E-94F6-F6A16CC43AB3

Q35186322-BF044697-202F-40C1-9883-0A42C4B85E18

P2860

Q35186322-002D678B-90A3-4B1C-A3F4-A0486C673DCD

Q35186322-0C02F210-8AC7-4674-AFDC-A0910E554B40

Q35186322-0DCA970A-6EA9-402D-9CEE-1B598A5376DD

Q35186322-1D4D68F2-8143-46B0-81C4-44B0E71EAFB5

Q35186322-246832F6-3A49-42F2-98F2-43FF08D26EEB

Q35186322-25D2FE3A-48B1-48CD-9F9E-3A83141A1ECA

Q35186322-27178C1E-1145-424E-B081-2430F74EEE4E

Q35186322-2AF9386B-E627-4FD4-B055-52C77FA1EE4D

Q35186322-2E7DF041-1654-4B6F-83CF-733E931F063E

Q35186322-3A1B84ED-9E29-4D24-9E57-05B7F84ED520

P304

Q35186322-F1074B7E-FF22-4F05-B931-9C5FCB43BFCC

P31

Q35186322-5EECF7B1-9CB7-4D2E-BF1E-0B972DB92695

P356

Q35186322-B4E40B00-FFC3-49B5-AE3B-BFEA35C68BF7

P433

Q35186322-54FDFB1B-7000-404B-99B7-89B920252DD0

P478

Q35186322-6C60BAC0-11CF-45C4-8374-F95CE44C6A87

P50

Q35186322-1EBEADC1-9531-427F-A9C7-B1292EBF7244

P577

Q35186322-A2901867-4156-434A-AEE2-83C78A236F9A

P5875

Q35186322-1E53A8F1-6DCA-4846-8C7E-3E7D811EDF8C

P698

Q35186322-D611C008-071A-44C3-B949-4E4D35F20B66

P932

Q35186322-53341034-8F7E-4DCC-AC0D-E294C043448B

P356

J.LEUKRES.2011.05.004

P1433

Leukemia Research

P1476

Identification of a novel, tis ...... cute megakaryoblastic leukemia

@en

P2093

Brian P Sorrentino

http://www.w3.org/2001/XMLSchema#string

Patrick K Campbell

http://www.w3.org/2001/XMLSchema#string

Sheng Zhou

http://www.w3.org/2001/XMLSchema#string

Shengping Yang

http://www.w3.org/2001/XMLSchema#string

Yang Zong

http://www.w3.org/2001/XMLSchema#string

P2860

A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance

Transcription factor GATA-1 and Down syndrome leukemogenesis

Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia

MatInspector and beyond: promoter analysis based on transcription factor binding sites

Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene.

Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells.

Genome-wide analysis of alternative promoters of human genes using a custom promoter tiling array.

Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage.

Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients.

Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib.

P304

1321-1329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.LEUKRES.2011.05.004

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey Rubnitz

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51190681

http://www.w3.org/2001/XMLSchema#string

P698

21640380

http://www.w3.org/2001/XMLSchema#string

P932

3163718

http://www.w3.org/2001/XMLSchema#string